Ruhrland Hospital
Weg, Hesse, 45239, Germany
NCT Number: NCT01037439
The objective of this study is to compare the modified adaptive servoventilation control algorithm of the with the standardised algorithms of routinely-used servoventilation processes (AutoSet CS2) in terms of the effect on obstructive and central events. The aim is to normalise breathing during sleep and hence eliminate the sleep-related breathing disorder, resulting in even more effective treatment of nocturnal breathing disorders in patients with cardiovascular diseases and sleep apnoea, to ensure optimum therapy success.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Weg, Hesse, 45239, Germany
Patients with cardiovascular disorders frequently suffer from sleep-related respiratory disorders (SRRD), such as obstructive sleep apnea (OSA) or a specific form of central sleep apnea, Cheyne-Stokes breathing (CSB, periodic breathing). However there is also a significant incidence of complex nocturnal breathing disorders, with both obstructive and central components. Sleep-related breathing disorders of this kind cause decreases in arterial oxygen saturation through brief hypopneas and apneas. Disturbed breathing also causes the patient to wake frequently during the night (arousals), usually during the hyperventilatory phase of CSB. Repeated arousals cause fragmentation of sleep, and therefore a deep sleep deficit. This leads to increased sleepiness during the day and impaired cognitive performance.
Previous studies have shown that Cheyne-Stokes breathing can be treated effectively with adaptive servoventilation. An enhancement to the routinely used algorithm (AutoSet CS2) has been created which allows the algorithm to differentiate between obstructive events and Cheyne-Stokes breathing, and better respond to apneas and hypopneas to eliminate the sleep-related breathing disorder and normalise breathing during sleep.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pressure support ventilation adapts to meet a target ventilation level that is constantly being assessed
Other names: AutoSet CS2, Adapt SV
Time frame: 1 night sleep
number of breathing pauses that occur each hour of sleep
Time frame: 1 night sleep
average percentage of oxygen saturation in the blood
Time frame: 1 night sleep
Continuous Positive Airway Pressure requirement for elimination of nocturnal breathing disorders
Time frame: 1 night sleep
How much the CPAP pressure varies when mask leak occurs
Time frame: 1 night sleep
The minimum percentage of oxygen saturation recorded in the blood
ResMed
Industry
Comparison of a Modified Adaptive Servoventilation With Conventional Adaptive Servoventilation Processes in Terms of Efficacy Against Complex Nocturnal Breathing Disorders
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01124370
Apnea, Central Sleep Apnea
Lincoln, Nebraska, United States
View Trial DetailsNCT03532412
Apnea, Dyssomnias
Solingen, Germany
View Trial DetailsNCT03695900
Apnea, Apnea of Prematurity
Miami, Florida, United States
View Trial DetailsNCT01405313
Breathing-Related Sleep Disorder, Periodic Breathing
Bad Oeynhausen, North Rhine-Westphalia, Germany
View Trial Details